NVST vs. XRAY, IRTC, PBH, AXNX, IBRX, IOVA, RARE, SEM, FTRE, and RDNT
Should you be buying Envista stock or one of its competitors? The main competitors of Envista include DENTSPLY SIRONA (XRAY), iRhythm Technologies (IRTC), Prestige Consumer Healthcare (PBH), Axonics (AXNX), ImmunityBio (IBRX), Iovance Biotherapeutics (IOVA), Ultragenyx Pharmaceutical (RARE), Select Medical (SEM), Fortrea (FTRE), and RadNet (RDNT). These companies are all part of the "medical" sector.
Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation, community ranking and profitability.
DENTSPLY SIRONA has a net margin of -3.33% compared to Envista's net margin of -3.90%. DENTSPLY SIRONA's return on equity of 11.14% beat Envista's return on equity.
In the previous week, Envista and Envista both had 8 articles in the media. Envista's average media sentiment score of 1.14 beat DENTSPLY SIRONA's score of 0.91 indicating that Envista is being referred to more favorably in the media.
Envista currently has a consensus price target of $29.60, suggesting a potential upside of 45.96%. DENTSPLY SIRONA has a consensus price target of $39.50, suggesting a potential upside of 27.75%. Given Envista's higher possible upside, research analysts plainly believe Envista is more favorable than DENTSPLY SIRONA.
DENTSPLY SIRONA received 426 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.38% of users gave DENTSPLY SIRONA an outperform vote while only 40.91% of users gave Envista an outperform vote.
Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.
95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.3% of Envista shares are held by company insiders. Comparatively, 0.8% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Envista has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500.
Summary
DENTSPLY SIRONA beats Envista on 10 of the 17 factors compared between the two stocks.
Get Envista News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
